1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > World In Vitro Diagnostics - Market Opportunities and Forecasts, 2015 - 2022

In vitro diagnostics (IVD) is the technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues and other body fluids, which are derived from the human body to detect diseases, conditions and infections. The tests can be performed in stand-alone laboratory, hospital based laboratory and point of care. Some of the significant technologies incorporated in vitro diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.The world in vitro diagnostics market is estimated to garner $81.3 billion by 2022, registering a CAGR of 4.9% over the forecast period. Growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalised medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In addition, increasing incidences of colorectal cancer, neurological disorders, gynaecological diseases and others would boost the adoption of IVD devices and reagents. On the contrary, stringent government regulations and unfavourable reimbursement policies would limit the growth of the market. The rising demand for technologically advanced diagnostic devices and increased disposable income of consumers provides huge growth potential for IVD market.The report segments the market across different categories such as product type, techniques, application, end users and geography. Based on product types, the market is segmented into reagents, instruments, and services & software. Based on techniques, the market is segmented into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry and other clinical techniques. Similarly, based on indication, the market is further segmented into, infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal disorders and other indications. Based on end users, the market is categorised into standalone laboratory, hospitals academics & medical schools and others. The geographical breakdown and detailed analysis of each of the aforesaid segments are included for North America, Europe, Asia-Pacific and LAMEA.Companies are adopting acquisition and partnership as key development strategies in this market Roche diagnostics, Abbott, Danaher Corporation are few of the dominant players in the IVD market. Other companies include Johnson and Johnson, Sysmex Corporation, Becton Dickinson, bioMrieux, Thermo Fisher Scientific, Inc., Ortho-Clinical Diagnostics, Siemens AGand Alere Inc. The comprehensive competitive analysis and profiles of major market players mentioned above are profiled in the report.

KEY BENEFITS
FOR STAKEHOLDERS:This report provides an extensive analysis of the current and emerging trends and dynamics in the world IVD market.Geographically, the world IVD market is analyzed based on various regions such as North America, Europe, Asia-Pacific and LAMEA.This report entails the detailed quantitative analysis of the current market and estimations from 2015 to 2022, which assists in identifying the prevailing market opportunities.Exhaustive analysis of the world IVD market by techniques helps in understanding the variants of IVD testing techniques that will gain prominence in the future.Competitive intelligence highlights the business practices followed by leading market players across various geographies.SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.IVD MARKET KEY SEGMENTS:By Product typeReagentsInstruments,Software & ServicesBy TechniquesImmunodiagnosticsBlood TestingMolecular DiagnosticsTissue DiagnosticsClinical ChemistryOther Clinical TechniquesBy ApplicationInfectious DiseasesCancerCardiac DiseasesImmune System DisordersNephrological DiseasesGastrointestinal DiseasesOther IndicationsBy End UsersStandalone LaboratoryHospitalsAcademic & Medical SchoolsOthersBy GeographyNorth AmericaCanadaU.SMexicoEuropeGermanyFranceU.K.OthersAsia-PacificIndiaChinaJapanAustraliaOthersLAMEALatin AmericaMiddle EastAfrica

Table Of Contents

World In Vitro Diagnostics - Market Opportunities and Forecasts, 2015 - 2022
Table of ContentsCHAPTER 1 INTRODUCTION1.1 Report description1.2 Key benefits1.3 Key market segments1.4 Research methodology1.4.1 Secondary research1.4.2 Primary research1.4.3 Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARY2.1 CXO perspective2.2 Market beyond: what to expect by 20272.2.1 Base case scenario2.2.2 Rapid growth scenario2.2.3 Diminishing growth scenarioCHAPTER 3 MARKET OVERVIEW3.1 Market definition and scope3.2 Key findings3.2.1 Top impacting factors3.2.2 Top investment pockets3.2.3 Top winning strategies3.3 Porter five forces analysis3.3.1 Bargaining power of supplier3.3.2 Bargaining power of buyers3.3.3 Low threat of new entrants3.3.4 Threat of substitute3.3.5 Competitive rivalry3.4 Government regulations3.5 Value chain analysis3.6 Case studies3.6.1 Case Study 1: Positioning of new IVD Platform by Life Science3.6.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system3.7 Research andamp; Analysis3.7.1 Clinical Trials of research studies conducted for IVD market3.8 Significant Progressions in IVD technologies3.8.1 Total Laboratory Automation (TLA)3.8.2 Evolving markets in digital pathology3.8.3 Omics and Genetics tests in IVD3.8.4 Point-of-Care testing3.8.5 Emerging technologies diagnostics and influence on IVD3.9 Market dynamics3.9.1 Drivers3.9.1.1 Increasing incidences of chronic and infectious diseases3.9.1.2 Technological advancements in IVD3.9.1.3 Emergence of minimal invasive technologies3.9.1.4 Increasing government expenditures on healthcare3.9.1.5 Increase in popularity personalized medicine approach3.9.2 Restraints3.9.2.1 Unclear reimbursement policies3.9.2.2 Stringent Regulatory policies3.9.3 Opportunities3.9.3.1 Potential Opportunities for outsourcing3.9.3.2 Convergence of new Technologies.CHAPTER 4 WORLD IVD MARKET, BY PRODUCT TYPE, 2014-20224.1 Overview4.1.1 Market size and forecast4.2 Reagents4.2.1 Key market trends4.2.2 Key growth factors and opportunities4.2.3 Market size and forecast4.3 Instruments4.3.1 Key market trends4.3.2 Key growth factors and opportunities4.3.3 Market size and forecast4.4 Software and services4.4.1 Key market trends4.4.2 Key growth factors and opportunities4.4.3 Market size and forecastCHAPTER 5 WORLD IVD MARKET, BY TECHNIQUES, 2014-20225.1 Immunodiagnostics5.1.1 Key market trends5.1.2 Key growth factors and opportunities5.1.3 Market size and forecast5.2 Blood testing5.2.1 Key market trends5.2.2 Key growth factors and opportunities5.2.3 Market size and forecast5.3 Molecular diagnostics5.3.1 Key market trends5.3.2 Key growth factors and opportunities5.3.3 Market size and forecast5.4 Tissue diagnostics5.4.1 Key market trends5.4.2 Key growth factors and opportunities5.4.3 Market size and forecast5.5 Clinical chemistry5.5.1 Key market trends5.5.2 Key growth factors and opportunities5.5.3 Market size and forecast5.6 Other clinical techniques5.6.1 Key market trends5.6.2 Key growth factors and opportunities5.6.3 Market size and forecastCHAPTER 6 WORLD IVD MARKET, BY APPLICATION, 2014-20226.1 Infectious diseases6.1.1 Key market trends6.1.2 Key growth factors and opportunities6.1.3 Market size and forecast6.2 Cancer6.2.1 Key market trends6.2.2 Key growth factors and opportunities6.2.3 Market size and forecast6.3 Cardiac diseases6.3.1 Key market trends6.3.2 Key growth factors and opportunities6.3.3 Market size and forecast6.4 Immune system diseases6.4.1 Key market trends6.4.2 Key growth factors and opportunities6.4.3 Market size and forecast6.5 Nephrological diseases6.5.1 Key market trends6.5.2 Key growth factors and opportunities6.5.3 Market size and forecast6.6 Gastrointestinal diseases6.6.1 Key market trends6.6.2 Key growth factors and opportunities6.6.3 Market size and forecast6.7 Other indications6.7.1 Key market trends6.7.2Key growth factors and opportunities6.7.3Market size and forecastCHAPTER 7 WORLD IVD MARKET BY END USERS, 2014-20227.1 Standalone laboratories7.1.1 Market size and forecast7.2 Hospitals7.2.1 Key market trends7.2.2 Key growth factors and opportunities7.2.3 Market size and forecast7.3 Academic and medical schools7.3.1 Key market trends7.3.2 Key growth factors and opportunities7.3.3 Market size and forecast7.4 Others7.4.1 Key market trends7.4.2 Key growth factors and opportunities7.4.3 Market size and forecastCHAPTER 8 WORLD IVD MARKET BY GEOGRAPHY, 2014-20228.1 North America8.1.1 Key market trends8.1.2 Key growth factors and opportunities8.1.3 Market size and forecast8.1.4 United states8.1.4.1 Market size and forecast8.1.5 Canada8.1.5.1 Market size and forecast8.1.6 Mexico8.1.6.1 Market size and forecast8.2 Europe8.2.1 Key market trends8.2.2 Key growth factors and opportunities8.2.3 Market size and forecast8.2.4 Germany8.2.4.1 Market size and forecast8.2.5 France8.2.5.1 Market size and forecast8.2.6 United Kingdom8.2.6.1 Market size and forecast8.2.7 Others8.2.7.1 Market size and forecast8.3 Asia Pacific8.3.1 Key market trends8.3.2 Key growth factors and opportunities8.3.3 Market size and forecast8.3.4 India8.3.4.1 Market size and forecast8.3.5 China8.3.5.1 Market size and forecast8.3.6 Japan8.3.6.1 Market size and forecast8.3.7 Australia8.3.7.1 Market size and forecast8.3.8 Others8.3.8.1 Market size and forecast8.4 LAMEA8.4.1 Key market trends8.4.2 Key growth factors and opportunities8.4.3 Market size and forecast8.4.4 Latin America8.4.4.1 Market size and forecast8.4.5 Middle East8.4.5.1 Market size and forecast8.4.6 Africa8.4.6.1 Market size and forecastCHAPTER 9 COMPANY PROFILES9.1 Affymetrix Inc.9.1.1 Company overview9.1.2 Company snapshot9.1.3 Financial performance of Affymetrix Inc.9.1.4 Key Strategies and development9.1.5 SWOT analysis of Affymetrix9.2 Alere Inc.9.2.1 Company overview9.2.2 Company snapshot9.2.3 Business performance9.2.4 Key strategies and developments9.2.5 SWOT analysis of Alere9.3 Biomerieux9.3.1 Company overview9.3.2 Company snapshot9.3.3 Business performance9.3.4 Key strategies and developments9.3.5 SWOT analysis of BioMerieux9.4 Danaher Corporation.9.4.1 Company overview9.4.2 Company snapshot9.4.3 Business performance9.4.4 Key strategies and development9.4.5 SWOT analysis of Danaher Corporation9.5 Roche Diagnostics9.5.1 Company overview9.5.2 Company snapshot9.5.3 Business performance9.5.4 Key strategies and developments9.5.5 SWOT analysis of Roche Diagnostics9.6 Becton Dickinson and Company9.6.1 Company overview9.6.2 Company snapshot9.6.3 Business performance9.6.4 Key strategies and development9.6.5 SWOT analysis of Becton Dickinson and Company9.7 Bio-Rad Laboratories, Inc.9.7.1 Company overview9.7.2 Company snapshot9.7.3 Business performance9.7.4 Key strategies and developments9.7.5 SWOT analysis of Bio-Rad Laboratories, Inc.9.8 Abbott Laboratories9.8.1 Company overview9.8.2 Company snapshot9.8.3 Business performance9.8.4 Key strategies and developments9.8.5 SWOT analysis of Abbott Laboratories9.9 Bayer AG.9.9.1 Company overview9.9.2 Company snapshot9.9.3 Business performance9.9.4 Key strategies and development9.9.5 SWOT analysis of Bayer AG9.10 Arkray, Inc.9.10.1 Company overview9.10.2 Company snapshot9.10.3 Key strategies and development9.10.4 SWOT analysis of Arkray, Inc.9.11 Sysmex Corporation9.11.1 Company overview9.11.2 Company snapshot9.11.3 Business performance9.11.4 Key strategies and developments9.11.5 SWOT analysis of Sysmex Corporation9.12 Johnson andamp; Johnson Pvt Ltd.9.12.1 Company overview9.12.2 Company snapshot9.12.3 Business performance9.12.4 Key strategies and development9.12.5 SWOT analysis of Johnson andamp; Johnson Pvt Ltd.9.13 Siemens AG9.13.1 Company overview9.13.2 Company snapshot9.13.3 Business performance9.13.4 Key strategies and development9.13.5 SWOT analysis of Siemens AGList of FiguresFIG. 1 WORLD IVD MARKET SNAPSHOTFIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)FIG. 4 TOP IMPACTING FACTORSFIG. 5 TOP INVESTMENT POCKETS OF IVD MARKET BY TECHNIQUES 2014-2022.FIG. 6 TOP WINNING STRATEGIESFIG. 7 TOP WINNING STRATEGIESFIG. 8 VALUE CHAIN ANALYSIS FOR IVD MARKETFIG. 9 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE, 2012-2014, $MILLIONFIG. 10 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE BY SEGMENTSFIG. 11 KEY FINANCIALS OF AFFYMETRIX INC.CORPORATION REVENUE BY GEOGRAPHYFIG. 12 SWOT ANALYSIS OF AFFYMETRIX INC.FIG. 13 KEY FINANCIALS OF ALERE INC. REVENUE, 2012-2014, $MILLIONFIG. 14 ALERE INC., % NET SALES BY BUSINESS SEGMENTS, 2014FIG. 15 ALERE INC., % NET SALES BY GEOGRAPHY, 2014FIG. 16 SWOT ANALYSIS OF ALERE INC.FIG. 17 KEY FINANCIALS OF BIOMERIEUX REVENUE, 2011-2014, $MILLIONFIG. 18 BIOMERIEUX, % NET SALES BY TECHNOLOGY, 2014FIG. 19 BIOMERIEUX, % NET SALES BY GEOGRAPHY, 2014FIG. 20 SWOT ANALYSIS OF BIOMERIEUXFIG. 21 DANAHER CORPORATION, % NET SALES BY BUSINESS SEGMENT, 2014FIG. 22 DANAHER CORPORATION, % NET SALES BY GEOGRAPHY, 2014FIG. 23 SWOT ANALYSIS OF DANAHER CORPORATIONFIG. 24 KEY FINANCIALS OF ROCHE DIAGNOSTICS REVENUE, 2012-2014, $MILLIONFIG. 25 ROCHE DIAGNOSTICS, % NET SALES BY BUSINESS SEGMENT, 2014FIG. 26 ROCHE DIAGNOSTICS, % NET SALES BY GEOGRAPHY, 2014FIG. 27 SWOT ANALYSIS OF ROCHE DIAGNOSTICSFIG. 28 KEY FINANCIALS OF BECTON, DICKINSON AND COMPANY REVENUE, 2011-2014, $MILLIONFIG. 29 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY REVENUES BY SEGMENT 2014FIG. 30 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY SALES BY GEOGRAPHY 2014FIG. 31 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANYFIG. 32 KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUE, 2012-2014, $MILLIONFIG. 33 BIO RAD LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014FIG. 34 BIO RAD LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014FIG. 35 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.FIG. 36 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLIONFIG. 37 ABBOTT LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014FIG. 38 ABBOTT LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014FIG. 39 SWOT ANALYSIS OF ABBOTT LABORATORIESFIG. 40 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLIONFIG. 41 BAYER AG, % REVENUE BY BUSINESS SEGMENT, 2014FIG. 42 SWOT ANALYSIS OF BAYER AGFIG. 43 SWOT ANALYSIS OF ARKRAY, INC.FIG. 44 KEY FINANCIALS OF SYSMEX CORPORATION REVENUE, 2012-2014, $MILLIONFIG. 45 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014FIG. 46 SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014FIG. 47 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)FIG. 48 SWOT ANALYSIS OF SYSMEX CORPORATIONFIG. 49 KEY FINANCIALS OF JOHNSON andamp; JOHSNON $MILLION (2012-2014)FIG. 50 FINANCIAL REVENUES BY SEGMENTS (2014)FIG. 51 FINANCIAL REVENUES BY GEOGRAPHY (2014)FIG. 52 SWOT ANALYSIS OF JOHNSON andamp; JOHNSON PVT LTD.FIG. 53FIG. 54 SIEMENS AG., % REVENUE BY BUSINESS SEGMENT, 2014FIG. 55 SIEMENS AG., % REVENUE BY GEOGRAPHY, 2014FIG. 56 SWOT ANALYSIS OF SIEMENS AGList of TableTABLE 1 WORLD IVD BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)TABLE 2 WORLD IVD RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)TABLE 3 WORLD IVD DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)TABLE 4 PORTERS FIVE FORCES ANALYSISTABLE 5 CLINICAL TRIALS - IN VITRO DIAGNOSTIC DEVICESTABLE 6 GLOBAL INCIDENCES OF DISEASESTABLE 7 WORLD IVD MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)TABLE 8 WORLD IVD REAGENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 9 WORLD IVD INSTRUMENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 10 WORLD IVD SOFTWARE AND SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 11 WORLD IVD MARKET BY TECHNIQUE, 2014-2022 ($MILLION)TABLE 12 WORLD IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 13 WORLD IVD BLOOD TESTING TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 14 WORLD IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 15 WORLD IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2014-2022, ($MILLION)TABLE 16 WORLD IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 17 WORLD IVD OTHER CLINICAL TECHNIQUES MARKET, BY GEOGRAPHY, 2014-2022, ($MILLION)TABLE 18 WORLD IVD MARKET, BY INDICATION, 2014-2022 ($MILLION)TABLE 19 WORLD IVD INFECTIOUS DISEASES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 20 WORLD IVD CANCER MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 21 WORLD IVD CARDIAC DISEASES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 22 WORLD IVD IMMUNE SYSTEM DISORDER MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 23 WORLD IVD NEPHROLOGICAL DISEASES MARKET, BY GEOGRAPHY, 2014-2022, ($MILLION)TABLE 24 WORLD IVD GASTRINTESTINAL DISEASES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 25 WORLD IVD OTHER INDICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 26 WORLD IVD MARKET, BY END USER, 2014-2022, ($MILLION)TABLE 27 WORLD IVD STANDALONE LABORATORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 28 WORLD IVD HOSPITALS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 29 WORLD IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY GEOGRAPHY, 2014- 2022 ($MILLION)TABLE 30 WORLD IVD OTHERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 31 WORLD IVD MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)TABLE 32 NORTH AMERICA IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)TABLE 33 UNITED STATES IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 34 CANADA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 35 MEXICO IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 36 EUROPE IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)TABLE 37 GERMANY IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 38 FRANCE IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 39 UNITED KINGDOM IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 40 OTHERS EUROPEAN IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 41 ASIA PACIFIC IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)TABLE 42 INDIA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 43 CHINA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 44 JAPAN IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 45 CATEGORIZATION OF IVD DEVICESTABLE 46 AUSTRALIA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 47 OTHERS IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 48 LAMEA IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)TABLE 49 LATIN AMERICA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 50 MIDDLE EAST IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 51 AFRICA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)TABLE 52 COMPANY SNAPSHOT OF AFFYMETRIX INC.TABLE 53 ALERE INC. COMPANY SNAPSHOTTABLE 54 BIOMERIEUX COMPANY SNAPSHOTTABLE 55 DANAHER CORPORATION COMPANY SNAPSHOTTABLE 56 ROCHE DIAGNOSTICS COMPANY SNAPSHOTTABLE 57 BECTON DICKINSON AND COMPANY SNAPSHOTTABLE 58 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOTTABLE 59 ABBOTT LABORATORIES SNAPSHOTTABLE 60 BAYER AG COMPANY SNAPSHOTTABLE 61 ARKRAY, INC. COMPANY SNAPSHOTTABLE 62 SYSMEX CORPORATION COMPANY SNAPSHOTTABLE 63 JOHNSON andamp; JOHNSON PVT LTD. COMPANY SNAPSHOTTABLE 64 SIEMENS AGCOMPANY SNAPSHOT

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Point of Care Diagnostics, BCC Research

Point of Care Diagnostics, BCC Research

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Review business opportunities in the thriving near-patient testing market. - Learn about the impact of chronic diseases, growing and aging populations. - Receive information about ...

2016 World In Vitro Diagnostic Instrumentation Review

2016 World In Vitro Diagnostic Instrumentation Review

  • $ 6500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com reviews operating characteristics and features of major automated and semi-automated high-, medium-, and low-volume/POC in vitro diagnostic systems within the ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.